| Symbol |
Name |
|
ABCC8
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 8
|
|
ABCG2
|
ATP-binding cassette, sub-family G (WHITE), member 2 (Junior blood group)
|
|
ACTA2
|
actin, alpha 2, smooth muscle, aorta
|
|
ACVR1
|
activin A receptor, type I
|
|
ADAM15
|
ADAM metallopeptidase domain 15
|
|
ADAM3A
|
ADAM metallopeptidase domain 3A (pseudogene)
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
|
AHCY
|
adenosylhomocysteinase
|
|
AIFM1
|
apoptosis-inducing factor, mitochondrion-associated, 1
|
|
AKAP12
|
A kinase (PRKA) anchor protein 12
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
ALB
|
albumin
|
|
ALK
|
anaplastic lymphoma receptor tyrosine kinase
|
|
AMACR
|
alpha-methylacyl-CoA racemase
|
|
ANO1
|
anoctamin 1, calcium activated chloride channel
|
|
ANXA10
|
annexin A10
|
|
ANXA2
|
annexin A2
|
|
APP
|
amyloid beta (A4) precursor protein
|
|
AQP1
|
aquaporin 1 (Colton blood group)
|
|
AQP4
|
aquaporin 4
|
|
AQP5
|
aquaporin 5
|
|
ATM
|
ATM serine/threonine kinase
|
|
ATP7B
|
ATPase, Cu++ transporting, beta polypeptide
|
|
ATRX
|
alpha thalassemia/mental retardation syndrome X-linked
|
|
B2M
|
beta-2-microglobulin
|
|
BACH2
|
BTB and CNC homology 1, basic leucine zipper transcription factor 2
|
|
BAD
|
BCL2-associated agonist of cell death
|
|
BANK1
|
B-cell scaffold protein with ankyrin repeats 1
|
|
BAX
|
BCL2-associated X protein
|
|
BCL10
|
B-cell CLL/lymphoma 10
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL6
|
B-cell CLL/lymphoma 6
|
|
BCL7A
|
B-cell CLL/lymphoma 7A
|
|
BDNF
|
brain-derived neurotrophic factor
|
|
BIRC3
|
baculoviral IAP repeat containing 3
|
|
BIRC5
|
baculoviral IAP repeat containing 5
|
|
BIRC7
|
baculoviral IAP repeat containing 7
|
|
BLM
|
Bloom syndrome, RecQ helicase-like
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BRD2
|
bromodomain containing 2
|
|
BRD4
|
bromodomain containing 4
|
|
BUB1
|
BUB1 mitotic checkpoint serine/threonine kinase
|
|
BUB1B
|
BUB1 mitotic checkpoint serine/threonine kinase B
|
|
C1QTNF5
|
C1q and tumor necrosis factor related protein 5
|
|
C4A
|
complement component 4A (Rodgers blood group)
|
|
C4B
|
complement component 4B (Chido blood group)
|
|
CA12
|
carbonic anhydrase XII
|
|
CA9
|
carbonic anhydrase IX
|
|
CAMTA1
|
calmodulin binding transcription activator 1
|
|
CARD11
|
caspase recruitment domain family, member 11
|
|
CASP3
|
caspase 3, apoptosis-related cysteine peptidase
|
|
CASR
|
calcium-sensing receptor
|
|
CAV1
|
caveolin 1, caveolae protein, 22kDa
|
|
CAV2
|
caveolin 2
|
|
CAV3
|
caveolin 3
|
|
CCL19
|
chemokine (C-C motif) ligand 19
|
|
CCNB1
|
cyclin B1
|
|
CCND1
|
cyclin D1
|
|
CCND3
|
cyclin D3
|
|
CCNE1
|
cyclin E1
|
|
CCNH
|
cyclin H
|
|
CCR2
|
chemokine (C-C motif) receptor 2
|
|
CCR7
|
chemokine (C-C motif) receptor 7
|
|
CD19
|
CD19 molecule
|
|
CD27
|
CD27 molecule
|
|
CD40
|
CD40 molecule, TNF receptor superfamily member 5
|
|
CD44
|
CD44 molecule (Indian blood group)
|
|
CD47
|
CD47 molecule
|
|
CD5
|
CD5 molecule
|
|
CD55
|
CD55 molecule, decay accelerating factor for complement (Cromer blood group)
|
|
CD58
|
CD58 molecule
|
|
CD59
|
CD59 molecule, complement regulatory protein
|
|
CD79B
|
CD79b molecule, immunoglobulin-associated beta
|
|
CD81
|
CD81 molecule
|
|
CD99
|
CD99 molecule
|
|
CDA
|
cytidine deaminase
|
|
CDC7
|
cell division cycle 7
|
|
CDC73
|
cell division cycle 73
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CDK1
|
cyclin-dependent kinase 1
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CDKN2B
|
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4)
|
|
CDX2
|
caudal type homeobox 2
|
|
CES2
|
carboxylesterase 2
|
|
CFAP69
|
cilia and flagella associated protein 69
|
|
CFLAR
|
CASP8 and FADD-like apoptosis regulator
|
|
CFTR
|
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)
|
|
CHEK2
|
checkpoint kinase 2
|
|
CIITA
|
class II, major histocompatibility complex, transactivator
|
|
CLDN1
|
claudin 1
|
|
CLDN4
|
claudin 4
|
|
CNR2
|
cannabinoid receptor 2 (macrophage)
|
|
CNTN1
|
contactin 1
|
|
COL4A5
|
collagen, type IV, alpha 5
|
|
COL4A6
|
collagen, type IV, alpha 6
|
|
CR2
|
complement component (3d/Epstein Barr virus) receptor 2
|
|
CRP
|
C-reactive protein, pentraxin-related
|
|
CSF1R
|
colony stimulating factor 1 receptor
|
|
CSNK1A1
|
casein kinase 1, alpha 1
|
|
CT45A1
|
cancer/testis antigen family 45, member A1
|
|
CTGF
|
connective tissue growth factor
|
|
CTLA4
|
cytotoxic T-lymphocyte-associated protein 4
|
|
CTNNA1
|
catenin (cadherin-associated protein), alpha 1, 102kDa
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CXCL10
|
chemokine (C-X-C motif) ligand 10
|
|
CXCL11
|
chemokine (C-X-C motif) ligand 11
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
|
CXCL5
|
chemokine (C-X-C motif) ligand 5
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CXCL9
|
chemokine (C-X-C motif) ligand 9
|
|
CXCR3
|
chemokine (C-X-C motif) receptor 3
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
CYBA
|
cytochrome b-245, alpha polypeptide
|
|
CYP11B1
|
cytochrome P450, family 11, subfamily B, polypeptide 1
|
|
CYP11B2
|
cytochrome P450, family 11, subfamily B, polypeptide 2
|
|
DDAH1
|
dimethylarginine dimethylaminohydrolase 1
|
|
DDC
|
dopa decarboxylase (aromatic L-amino acid decarboxylase)
|
|
DIO1
|
deiodinase, iodothyronine, type I
|
|
DIO2
|
deiodinase, iodothyronine, type II
|
|
DMBT1
|
deleted in malignant brain tumors 1
|
|
DNMT3B
|
DNA (cytosine-5-)-methyltransferase 3 beta
|
|
DPP4
|
dipeptidyl-peptidase 4
|
|
DUT
|
deoxyuridine triphosphatase
|
|
DUX4L1
|
double homeobox 4 like 1
|
|
EBI3
|
Epstein-Barr virus induced 3
|
|
EGFR
|
epidermal growth factor receptor
|
|
ELAVL1
|
ELAV like RNA binding protein 1
|
|
ENO2
|
enolase 2 (gamma, neuronal)
|
|
EPHX1
|
epoxide hydrolase 1, microsomal (xenobiotic)
|
|
EPO
|
erythropoietin
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERCC2
|
excision repair cross-complementation group 2
|
|
ERG
|
v-ets avian erythroblastosis virus E26 oncogene homolog
|
|
ETS1
|
v-ets avian erythroblastosis virus E26 oncogene homolog 1
|
|
EWSR1
|
EWS RNA-binding protein 1
|
|
EZR
|
ezrin
|
|
FABP7
|
fatty acid binding protein 7, brain
|
|
FAS
|
Fas cell surface death receptor
|
|
FBN1
|
fibrillin 1
|
|
FBXO10
|
F-box protein 10
|
|
FCER2
|
Fc fragment of IgE, low affinity II, receptor for (CD23)
|
|
FCGR2A
|
Fc fragment of IgG, low affinity IIa, receptor (CD32)
|
|
FCGR3A
|
Fc fragment of IgG, low affinity IIIa, receptor (CD16a)
|
|
FHIT
|
fragile histidine triad
|
|
FIGF
|
c-fos induced growth factor (vascular endothelial growth factor D)
|
|
FLI1
|
Fli-1 proto-oncogene, ETS transcription factor
|
|
FLT4
|
fms-related tyrosine kinase 4
|
|
FMR1
|
fragile X mental retardation 1
|
|
FOXL2
|
forkhead box L2
|
|
FOXM1
|
forkhead box M1
|
|
FOXO1
|
forkhead box O1
|
|
FOXP1
|
forkhead box P1
|
|
FOXP3
|
forkhead box P3
|
|
GABRA1
|
gamma-aminobutyric acid (GABA) A receptor, alpha 1
|
|
GATA3
|
GATA binding protein 3
|
|
GBA
|
glucosidase, beta, acid
|
|
GC
|
group-specific component (vitamin D binding protein)
|
|
GCSAM
|
germinal center-associated, signaling and motility
|
|
GFAP
|
glial fibrillary acidic protein
|
|
GKN1
|
gastrokine 1
|
|
GKN2
|
gastrokine 2
|
|
GLI1
|
GLI family zinc finger 1
|
|
GLI2
|
GLI family zinc finger 2
|
|
GLI3
|
GLI family zinc finger 3
|
|
GNA13
|
guanine nucleotide binding protein (G protein), alpha 13
|
|
GNAS
|
GNAS complex locus
|
|
GNB3
|
guanine nucleotide binding protein (G protein), beta polypeptide 3
|
|
GSTA1
|
glutathione S-transferase alpha 1
|
|
GSTM1
|
glutathione S-transferase mu 1
|
|
GSTP1
|
glutathione S-transferase pi 1
|
|
GSTT1
|
glutathione S-transferase theta 1
|
|
GYPC
|
glycophorin C (Gerbich blood group)
|
|
H2AFX
|
H2A histone family, member X
|
|
H3F3A
|
H3 histone, family 3A
|
|
HADH
|
hydroxyacyl-CoA dehydrogenase
|
|
HAMP
|
hepcidin antimicrobial peptide
|
|
HCAR2
|
hydroxycarboxylic acid receptor 2
|
|
HCAR3
|
hydroxycarboxylic acid receptor 3
|
|
HDAC1
|
histone deacetylase 1
|
|
HDAC2
|
histone deacetylase 2
|
|
HDAC6
|
histone deacetylase 6
|
|
HGFAC
|
HGF activator
|
|
HIC1
|
hypermethylated in cancer 1
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HIST3H2BB
|
histone cluster 3, H2bb
|
|
HIST3H3
|
histone cluster 3, H3
|
|
HIST4H4
|
histone cluster 4, H4
|
|
HLA-A
|
major histocompatibility complex, class I, A
|
|
HLA-B
|
major histocompatibility complex, class I, B
|
|
HMGB1
|
high mobility group box 1
|
|
HSP90B1
|
heat shock protein 90kDa beta (Grp94), member 1
|
|
HSPA4
|
heat shock 70kDa protein 4
|
|
HTRA2
|
HtrA serine peptidase 2
|
|
ICAM1
|
intercellular adhesion molecule 1
|
|
ICOS
|
inducible T-cell co-stimulator
|
|
ICOSLG
|
inducible T-cell co-stimulator ligand
|
|
IDH1
|
isocitrate dehydrogenase 1 (NADP+), soluble
|
|
IDH2
|
isocitrate dehydrogenase 2 (NADP+), mitochondrial
|
|
IDO1
|
indoleamine 2,3-dioxygenase 1
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
|
IGF2
|
insulin-like growth factor 2
|
|
IGF2BP3
|
insulin-like growth factor 2 mRNA binding protein 3
|
|
IGH
|
immunoglobulin heavy locus
|
|
IKBKB
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta
|
|
IL10
|
interleukin 10
|
|
IL13RA2
|
interleukin 13 receptor, alpha 2
|
|
IL1A
|
interleukin 1, alpha
|
|
IL1B
|
interleukin 1, beta
|
|
IL21
|
interleukin 21
|
|
IL2RA
|
interleukin 2 receptor, alpha
|
|
IL4
|
interleukin 4
|
|
IL4R
|
interleukin 4 receptor
|
|
IL5
|
interleukin 5
|
|
IL6
|
interleukin 6
|
|
IL7
|
interleukin 7
|
|
IL7R
|
interleukin 7 receptor
|
|
IL9R
|
interleukin 9 receptor
|
|
IMP3
|
IMP3, U3 small nucleolar ribonucleoprotein
|
|
IQGAP1
|
IQ motif containing GTPase activating protein 1
|
|
IRAK1
|
interleukin-1 receptor-associated kinase 1
|
|
IRF4
|
interferon regulatory factor 4
|
|
IRF8
|
interferon regulatory factor 8
|
|
ISL1
|
ISL LIM homeobox 1
|
|
IYD
|
iodotyrosine deiodinase
|
|
JAK2
|
Janus kinase 2
|
|
KAT2B
|
K(lysine) acetyltransferase 2B
|
|
KCNN4
|
potassium channel, calcium activated intermediate/small conductance subfamily N alpha, member 4
|
|
KDR
|
kinase insert domain receptor
|
|
KDSR
|
3-ketodihydrosphingosine reductase
|
|
KIAA1549
|
KIAA1549
|
|
KIF21A
|
kinesin family member 21A
|
|
KIR3DL1
|
killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
|
KMT2D
|
lysine (K)-specific methyltransferase 2D
|
|
KRT1
|
keratin 1, type II
|
|
KRT17
|
keratin 17, type I
|
|
KRT7
|
keratin 7, type II
|
|
KRT9
|
keratin 9, type I
|
|
LEPR
|
leptin receptor
|
|
LGALS3
|
lectin, galactoside-binding, soluble, 3
|
|
LMO2
|
LIM domain only 2 (rhombotin-like 1)
|
|
LPP
|
LIM domain containing preferred translocation partner in lipoma
|
|
LRRK2
|
leucine-rich repeat kinase 2
|
|
LTA
|
lymphotoxin alpha
|
|
LY6D
|
lymphocyte antigen 6 complex, locus D
|
|
MAD2L1
|
MAD2 mitotic arrest deficient-like 1 (yeast)
|
|
MAGEA3
|
melanoma antigen family A3
|
|
MALT1
|
MALT1 paracaspase
|
|
MAP1LC3A
|
microtubule-associated protein 1 light chain 3 alpha
|
|
MAP3K8
|
mitogen-activated protein kinase kinase kinase 8
|
|
MAP4
|
microtubule-associated protein 4
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MECP2
|
methyl CpG binding protein 2
|
|
MEF2B
|
myocyte enhancer factor 2B
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
MGMT
|
O-6-methylguanine-DNA methyltransferase
|
|
MIF
|
macrophage migration inhibitory factor (glycosylation-inhibiting factor)
|
|
MIR127
|
microRNA 127
|
|
MIR142
|
microRNA 142
|
|
MIR146B
|
microRNA 146b
|
|
MIR155
|
microRNA 155
|
|
MIR17
|
microRNA 17
|
|
MIR21
|
microRNA 21
|
|
MIR223
|
microRNA 223
|
|
MIR23A
|
microRNA 23a
|
|
MIR24-1
|
microRNA 24-1
|
|
MIR28
|
microRNA 28
|
|
MIR320D1
|
microRNA 320d-1
|
|
MIR34A
|
microRNA 34a
|
|
MIRLET7A1
|
microRNA let-7a-1
|
|
MKI67
|
marker of proliferation Ki-67
|
|
MLANA
|
melan-A
|
|
MME
|
membrane metallo-endopeptidase
|
|
MMP12
|
matrix metallopeptidase 12
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MRE11A
|
MRE11 meiotic recombination 11 homolog A (S. cerevisiae)
|
|
MS4A1
|
membrane-spanning 4-domains, subfamily A, member 1
|
|
MSC
|
musculin
|
|
MSI1
|
musashi RNA-binding protein 1
|
|
MTDH
|
metadherin
|
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H)
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MTR
|
5-methyltetrahydrofolate-homocysteine methyltransferase
|
|
MUC1
|
mucin 1, cell surface associated
|
|
MUC2
|
mucin 2, oligomeric mucus/gel-forming
|
|
MUC22
|
mucin 22
|
|
MUC5B
|
mucin 5B, oligomeric mucus/gel-forming
|
|
MUM1
|
melanoma associated antigen (mutated) 1
|
|
MYBL1
|
v-myb avian myeloblastosis viral oncogene homolog-like 1
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
MYD88
|
myeloid differentiation primary response 88
|
|
MYH9
|
myosin, heavy chain 9, non-muscle
|
|
MYOG
|
myogenin (myogenic factor 4)
|
|
MZB1
|
marginal zone B and B1 cell-specific protein
|
|
NAB2
|
NGFI-A binding protein 2 (EGR1 binding protein 2)
|
|
NBN
|
nibrin
|
|
NCAM1
|
neural cell adhesion molecule 1
|
|
NCF1
|
neutrophil cytosolic factor 1
|
|
NDUFV1
|
NADH dehydrogenase (ubiquinone) flavoprotein 1, 51kDa
|
|
NEWENTRY
|
Record to support submission of GeneRIFs for a gene not in Gene (human; man).
|
|
NFATC1
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NFKB2
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100)
|
|
NFKBIA
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha
|
|
NFKBIZ
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, zeta
|
|
NIPAL4
|
NIPA-like domain containing 4
|
|
NKX2-1
|
NK2 homeobox 1
|
|
NME1
|
NME/NM23 nucleoside diphosphate kinase 1
|
|
NOTCH1
|
notch 1
|
|
NPC2
|
Niemann-Pick disease, type C2
|
|
NR4A2
|
nuclear receptor subfamily 4, group A, member 2
|
|
NUMA1
|
nuclear mitotic apparatus protein 1
|
|
OLIG2
|
oligodendrocyte lineage transcription factor 2
|
|
ONECUT2
|
one cut homeobox 2
|
|
PARK2
|
parkin RBR E3 ubiquitin protein ligase
|
|
PAX2
|
paired box 2
|
|
PAX8
|
paired box 8
|
|
PCNA
|
proliferating cell nuclear antigen
|
|
PDCD1
|
programmed cell death 1
|
|
PDE4B
|
phosphodiesterase 4B, cAMP-specific
|
|
PDGFRA
|
platelet-derived growth factor receptor, alpha polypeptide
|
|
PDPN
|
podoplanin
|
|
PECAM1
|
platelet/endothelial cell adhesion molecule 1
|
|
PEPD
|
peptidase D
|
|
PGK1
|
phosphoglycerate kinase 1
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PIK3CG
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
|
|
PITX1
|
paired-like homeodomain 1
|
|
PLAGL1
|
pleiomorphic adenoma gene-like 1
|
|
PLCE1
|
phospholipase C, epsilon 1
|
|
PLK1
|
polo-like kinase 1
|
|
POMC
|
proopiomelanocortin
|
|
PON1
|
paraoxonase 1
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PPIA
|
peptidylprolyl isomerase A (cyclophilin A)
|
|
PPP1R14B
|
protein phosphatase 1, regulatory (inhibitor) subunit 14B
|
|
PRAME
|
preferentially expressed antigen in melanoma
|
|
PRDM1
|
PR domain containing 1, with ZNF domain
|
|
PRDM2
|
PR domain containing 2, with ZNF domain
|
|
PRKACA
|
protein kinase, cAMP-dependent, catalytic, alpha
|
|
PRKAR1A
|
protein kinase, cAMP-dependent, regulatory, type I, alpha
|
|
PRKCB
|
protein kinase C, beta
|
|
PRNP
|
prion protein
|
|
PRPH2
|
peripherin 2 (retinal degeneration, slow)
|
|
PSCA
|
prostate stem cell antigen
|
|
PSEN1
|
presenilin 1
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTH
|
parathyroid hormone
|
|
PTPN6
|
protein tyrosine phosphatase, non-receptor type 6
|
|
PTPRC
|
protein tyrosine phosphatase, receptor type, C
|
|
RAD50
|
RAD50 homolog (S. cerevisiae)
|
|
RANBP2
|
RAN binding protein 2
|
|
RB1
|
retinoblastoma 1
|
|
REL
|
v-rel avian reticuloendotheliosis viral oncogene homolog
|
|
RELA
|
v-rel avian reticuloendotheliosis viral oncogene homolog A
|
|
RET
|
ret proto-oncogene
|
|
RHOH
|
ras homolog family member H
|
|
RIPK4
|
receptor-interacting serine-threonine kinase 4
|
|
RNF31
|
ring finger protein 31
|
|
RPS6
|
ribosomal protein S6
|
|
RPS6KB1
|
ribosomal protein S6 kinase, 70kDa, polypeptide 1
|
|
RTN3
|
reticulon 3
|
|
RUVBL1
|
RuvB-like AAA ATPase 1
|
|
RUVBL2
|
RuvB-like AAA ATPase 2
|
|
S100B
|
S100 calcium binding protein B
|
|
S1PR1
|
sphingosine-1-phosphate receptor 1
|
|
S1PR2
|
sphingosine-1-phosphate receptor 2
|
|
SBDS
|
Shwachman-Bodian-Diamond syndrome
|
|
SDC1
|
syndecan 1
|
|
SERPINA9
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 9
|
|
SETD2
|
SET domain containing 2
|
|
SFTPC
|
surfactant protein C
|
|
SFTPD
|
surfactant protein D
|
|
SHH
|
sonic hedgehog
|
|
SHMT1
|
serine hydroxymethyltransferase 1 (soluble)
|
|
SIK2
|
salt-inducible kinase 2
|
|
SIRT1
|
sirtuin 1
|
|
SLC1A2
|
solute carrier family 1 (glial high affinity glutamate transporter), member 2
|
|
SLC2A1
|
solute carrier family 2 (facilitated glucose transporter), member 1
|
|
SNAI2
|
snail family zinc finger 2
|
|
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor)
|
|
SNCB
|
synuclein, beta
|
|
SNCG
|
synuclein, gamma (breast cancer-specific protein 1)
|
|
SOCS1
|
suppressor of cytokine signaling 1
|
|
SPARC
|
secreted protein, acidic, cysteine-rich (osteonectin)
|
|
SPRR1A
|
small proline-rich protein 1A
|
|
SPRY2
|
sprouty homolog 2 (Drosophila)
|
|
SSTR2
|
somatostatin receptor 2
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STAT6
|
signal transducer and activator of transcription 6, interleukin-4 induced
|
|
SYK
|
spleen tyrosine kinase
|
|
TCL1A
|
T-cell leukemia/lymphoma 1A
|
|
TERT
|
telomerase reverse transcriptase
|
|
TET2
|
tet methylcytosine dioxygenase 2
|
|
TFF2
|
trefoil factor 2
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TGFBR2
|
transforming growth factor, beta receptor II (70/80kDa)
|
|
TGM3
|
transglutaminase 3
|
|
TNF
|
tumor necrosis factor
|
|
TNFAIP3
|
tumor necrosis factor, alpha-induced protein 3
|
|
TNFRSF13C
|
tumor necrosis factor receptor superfamily, member 13C
|
|
TNFRSF1A
|
tumor necrosis factor receptor superfamily, member 1A
|
|
TNFRSF6B
|
tumor necrosis factor receptor superfamily, member 6b, decoy
|
|
TNFRSF8
|
tumor necrosis factor receptor superfamily, member 8
|
|
TNFRSF9
|
tumor necrosis factor receptor superfamily, member 9
|
|
TNFSF13
|
tumor necrosis factor (ligand) superfamily, member 13
|
|
TNIP1
|
TNFAIP3 interacting protein 1
|
|
TNIP2
|
TNFAIP3 interacting protein 2
|
|
TOP2A
|
topoisomerase (DNA) II alpha 170kDa
|
|
TP53
|
tumor protein p53
|
|
TRAF2
|
TNF receptor-associated factor 2
|
|
TREM1
|
triggering receptor expressed on myeloid cells 1
|
|
TSLP
|
thymic stromal lymphopoietin
|
|
TTF1
|
transcription termination factor, RNA polymerase I
|
|
TUBB2B
|
tubulin, beta 2B class IIb
|
|
TWIST1
|
twist family bHLH transcription factor 1
|
|
TXN
|
thioredoxin
|
|
TYMS
|
thymidylate synthetase
|
|
UCHL1
|
ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase)
|
|
UGT1A1
|
UDP glucuronosyltransferase 1 family, polypeptide A1
|
|
VDR
|
vitamin D (1,25- dihydroxyvitamin D3) receptor
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VEGFC
|
vascular endothelial growth factor C
|
|
WRN
|
Werner syndrome, RecQ helicase-like
|
|
WT1
|
Wilms tumor 1
|
|
XBP1
|
X-box binding protein 1
|
|
XCL1
|
chemokine (C motif) ligand 1
|
|
XCR1
|
chemokine (C motif) receptor 1
|
|
XIAP
|
X-linked inhibitor of apoptosis, E3 ubiquitin protein ligase
|
|
YWHAZ
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta
|
|
ZAP70
|
zeta-chain (TCR) associated protein kinase 70kDa
|
|
ZAR1
|
zygote arrest 1
|
|
ZEB1
|
zinc finger E-box binding homeobox 1
|
